Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

Clinical trial NCT00267306 · COMPLETED

Trial details

NCT number: NCT00267306
Sponsor: Facet Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Ulcerative Colitis

Start date: 2004-01-01
Primary completion: 2006-12-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.